SCHEMBL890725

SCHEMBL890725

Cc1ccc(S(=O)(=O)OCCCCOS(=O)(=O)c2ccc(C)cc2)cc1

nearest known ligand 0.50

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 4/20 0.50
CYP3A4 P08684 1/20 0.50
CYP2C9 P11712 1/20 0.50
CYP2C19 P33261 1/20 0.50
GAA P10253 2/20 0.48
CA1 P00915 3/20 0.47
CA9 Q16790 3/20 0.47
CA12 O43570 2/20 0.47
G6PD P11413 1/20 0.46
STAT3 P40763 1/20 0.45
PSMD10 O75832 1/20 0.45
CA2 P00918 2/20 0.45
CA3 P07451 1/20 0.45
CA6 P23280 1/20 0.45
CA5A P35218 1/20 0.45
CA7 P43166 1/20 0.45
CA5B Q9Y2D0 1/20 0.45
CYP24A1 Q07973 2/20 0.44
TLR9 Q9NR96 1/20 0.43
VDR P11473 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3545668 0.98 ALDH1A1 (0.48) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL4954181 0.98 ALDH1A1 (0.48) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL8483813 0.98 ALDH1A1 (0.48) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL4951882 0.98 ALDH1A1 (0.48) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL8484861 0.98 ALDH1A1 (0.48) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL11050599 0.98 ALDH1A1 (0.48) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL4815560 0.98 ALDH1A1 (0.48) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL4812770 0.98 ALDH1A1 (0.48) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL483847 0.96 ALDH1A1 (0.50) ALDH1A1CYP3A4CYP2C9CYP2C19GAA
SCHEMBL2550352 0.94 ALDH1A1 (0.50) ALDH1A1CYP3A4CYP2C9CYP2C19GAA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 181 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-114656389-A Synthesis method of 1-phenylpyrrolidine 河南大学 2022-06-24 CN claimed
US-5912306-A THERMOPLASTIC RESINS AND CROSSLINKED POLYAMINES HERCULES INCORPORATED (US) 1999-06-15 US claimed
EP-0553575-B1 Novel cationic polyamines useful as drainage aids and stabilizers for rosin-based sizing agents HERCULES INC (US) 1996-05-15 EP claimed
US-5393338-A Cationic compounds useful as drainage aids and stabilizers for rosin-based sizing agents HERCULES INCORPORATED (US) 1995-02-28 US claimed
EP-0553575-A1 Novel cationic polyamines useful as drainage aids and stabilizers for rosin-based sizing agents HERCULES INCORPORATED (US) 1993-08-04 EP claimed
WO-2025127092-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2025-06-19 WO disclosed
WO-2025088969-A1 COMPOSITION FOR FORMING CURED FILM, CURED FILM, ALIGNMENT MATERIAL, AND RETARDATION MATERIAL 日産化学株式会社 2025-05-01 WO disclosed
WO-2025079672-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2025-04-17 WO disclosed
WO-2025079671-A1 LIQUID CRYSTAL ALIGNMENT AGENT, LIQUID CRYSTAL ALIGNMENT FILM, AND LIQUID CRYSTAL DISPLAY ELEMENT 日産化学株式会社 2025-04-17 WO disclosed
US-20250107432-A1 DIVALENT EUROPIUM-ORGANIC COORDINATION COMPOUND AND METHOD FOR PRODUCING THE SAME BEEOLED GMBH (DE) 2025-03-27 US disclosed
EP-4528369-A1 LIQUID CRYSTAL ALIGNING AGENT, LIQUID CRYSTAL ALIGNMENT FILM AND LIQUID CRYSTAL DISPLAY ELEMENT Nissan Chemical Corporation (JP) 2025-03-26 EP disclosed
CN-119431417-A Divalent europium-organic coordination compound and preparation method thereof 蜜蜂OLED股份有限公司 2025-02-14 CN disclosed
US-4782126-A POLYEPOXIDE CURING AGENTS CIBA-GEIGY CORPORATION (US) 1988-11-01 US disclosed
US-4713417-A CURING AGENTS FOR POLYEPOXIDES CIBA-GEIGY CORP. (US) 1987-12-15 US disclosed
EP-0225282-A1 Process for the post-treatment of dyed cellulosic fibrous material CIBA-GEIGY AG (CH) 1987-06-10 EP disclosed
EP-0225281-A1 Auxiliary agent combination and its use as a textile-finishing agent CIBA-GEIGY AG (CH) 1987-06-10 EP disclosed
US-4587317-A ACID CATALYSTS CIBA-GEIGY CORPORATION (US) 1986-05-06 US disclosed
US-4348377-A RADIOPACITY BRACCO INDUSTRIA CHIMICA S.P.A. (IT) 1982-09-07 US disclosed
EP-0023992-A1 Derivatives of 2,4,6-triodo-isophthalic acid, process for their preparation and X-ray contrast agents containing them BRACCO INDUSTRIA CHIMICA Società per Azioni (IT) 1981-02-18 EP disclosed
US-4053402-A PROCESS FOR PRODUCING SULFONES KERNFORSCHUNGSANLAGE JULICH GMBH (DT) 1977-10-11 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20250107432-A1 DIVALENT EUROPIUM-ORGANIC COORDINATION COMPOUND AND METHOD FOR PRODUCING THE SAME ORC3, OR10J3, OSTC ALDH1A1 4707/4885CYP3A4 2707/4885CYP2C9 3899/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.